Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement.

The American journal of surgical pathology - 1 Nov 2024

Zhang Yuxiu, Li Anqi, Li Yimin, Ouyang Binshen, Wang Xuan, Zhang Lei, Xu Haimin, Gu Yijin, Lu Xinyuan, Dong Lei, Yi Hongmei, Wang Chaofu

Abstract excerpt

Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a rare form of aggressive B-cell lymphoma with limited molecular information reported regarding interferon regulatory factor 4 ( IRF4 ) status. Here, we presented 3 EBV-positive DLBCL cases with IRF4 rearrangement (EBV+DLBCL- IRF4 -R) verified by fluorescence in situ hybridization (FISH). Three patients, including 1 male and 2 females...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epstein-Barr Virus Infections

Share to Gene Rearrangement

Share to Herpesvirus 4, Human

Share to In Situ Hybridization, Fluorescence

Share to Interferon Regulatory Factors

Share to Lymphoma, Large B-Cell, Diffuse

Source

Identifiers

PMID: 39172106
DOI: 10.1097/PAS.0000000000002301

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement.PMID 39172106Read ↗

Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.Semantic proximity Read ↗

Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult populationSemantic proximity Read ↗

B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.Semantic proximity Read ↗

Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer’s ring in adultsSemantic proximity Read ↗

Molecular Pathogenesis of Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related GenesSemantic proximity Read ↗

Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patientsSemantic proximity Read ↗

Large B-cell Lymphoma with IRF4 rearrangement: a pitfall in the pathological diagnosis of lymphomaSemantic proximity Read ↗

Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes.Semantic proximity Read ↗

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphomaSemantic proximity Read ↗

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.Semantic proximity Read ↗

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.